Migraine medications linked to miscarriage risk
A recent study has shown that modern medications used to treat migraines may increase the risk of miscarriage by up to 40% during the first twenty weeks of pregnancy. The study involved 7,579 pregnancies and focused on CGRP antagonist drugs, which influence blood flow regulation and embryo implantation. No increased risk was observed with the use of propranolol. The researchers emphasized that these findings are observational and do not prove that the medications directly cause miscarriage. They called for further studies to assess the safety of these drugs during pregnancy and advised women to consult with healthcare providers before changing or discontinuing their treatment.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)